ES2145014T3 - Derivados de piperazina como inhibidores de la colagenasa. - Google Patents

Derivados de piperazina como inhibidores de la colagenasa.

Info

Publication number
ES2145014T3
ES2145014T3 ES92922404T ES92922404T ES2145014T3 ES 2145014 T3 ES2145014 T3 ES 2145014T3 ES 92922404 T ES92922404 T ES 92922404T ES 92922404 T ES92922404 T ES 92922404T ES 2145014 T3 ES2145014 T3 ES 2145014T3
Authority
ES
Spain
Prior art keywords
alkyl
nhch
piperazine derivatives
collagenase inhibitors
collagenase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92922404T
Other languages
English (en)
Inventor
Yukio Sugimura
Kazuhiko Tamaki
Tomowo Kobayashi
Kazuhiko Tanzawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of ES2145014T3 publication Critical patent/ES2145014T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

CONSTITUCION: UN NUEVO COMPUESTO REPRESENTADO POR LA FORMULA GENERAL (I), EN LA QUE R1 REPRESENTA -OR3 (SIENDO R3 H O ALKILO), NR4R5 (SIENDO R5 Y R5 CADA UNO H, ALKILO O ALCOXI), -NHCH(R6)CONR9R10 (SIENDO R9 Y R10 CADA UNO H, ALKILO O ALTERNATIVAMENTE NR9R10 SIENDO UN GRUPO HETEROCICLICO COMO UN TODO); Y R2 REPRESENTA H, ALKILO O ARILAKILO. EFECTO: YA QUE EL COMPUESTO TIENE UNA COLAGENASA DE TIPO IV DE ACTIVIDAD INHIBITORIA, ES UTIL COMO INHIBIDOR CONTRA LA INFILTRACION DE CANCER, VASCULARIZACION O METASTASIS DE CANCER.
ES92922404T 1991-11-08 1992-11-02 Derivados de piperazina como inhibidores de la colagenasa. Expired - Lifetime ES2145014T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29288491 1991-11-08

Publications (1)

Publication Number Publication Date
ES2145014T3 true ES2145014T3 (es) 2000-07-01

Family

ID=17787629

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92922404T Expired - Lifetime ES2145014T3 (es) 1991-11-08 1992-11-02 Derivados de piperazina como inhibidores de la colagenasa.

Country Status (17)

Country Link
US (1) US5643908A (es)
EP (1) EP0621270B1 (es)
JP (2) JPH05194414A (es)
KR (1) KR100255203B1 (es)
AT (1) ATE191713T1 (es)
AU (1) AU661058B2 (es)
CA (1) CA2123104A1 (es)
CZ (1) CZ112694A3 (es)
DE (1) DE69230916T2 (es)
DK (1) DK0621270T3 (es)
ES (1) ES2145014T3 (es)
FI (1) FI942094A (es)
GR (1) GR3033368T3 (es)
HU (1) HUT67374A (es)
NO (1) NO306507B1 (es)
RU (1) RU2091373C1 (es)
WO (1) WO1993009097A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9223904D0 (en) * 1992-11-13 1993-01-06 British Bio Technology Inhibition of cytokine production
CZ290145B6 (cs) * 1994-01-20 2002-06-12 British Biotech Pharmaceuticals Limited Inhibitory metaloproteinázy
AU2394795A (en) * 1994-04-28 1995-11-29 Du Pont Merck Pharmaceutical Company, The Hydroxamic acid and amino acid derivatives and their use as anti-arthritic agents
GB9411598D0 (en) * 1994-06-09 1994-08-03 Hoffmann La Roche Hydroxamic acid derivatives
GB9423914D0 (en) * 1994-11-26 1995-01-11 British Biotech Pharm Polyether derivatives as metalloproteinase inhibitors
US5919940A (en) * 1995-01-20 1999-07-06 British Biotech Pharmaceuticals Limited Metalloproteinase inhibitors
US5917090A (en) * 1995-06-30 1999-06-29 British Biotech Pharmaceuticals Ltd. Matrix metalloproteinase inhibitors
ES2164264T3 (es) 1995-11-23 2002-02-16 British Biotech Pharm Inhibidores de metaloproteinasas.
WO1997031901A1 (en) * 1996-02-29 1997-09-04 Mikael Bols Hydroxyhexahydropyridazines
US6462023B1 (en) 1996-09-10 2002-10-08 British Biotech Pharmaceuticals, Ltd. Cytostatic agents
US6953788B1 (en) 1996-09-19 2005-10-11 Aventis Pharmaceuticals Inc. 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
GB9803005D0 (en) 1998-02-12 1998-04-08 British Biotech Pharm Anti-inflammatory agents
US7253169B2 (en) * 1999-11-12 2007-08-07 Gliamed, Inc. Aza compounds, pharmaceutical compositions and methods of use
US6417189B1 (en) 1999-11-12 2002-07-09 Gpi Nil Holdings, Inc. AZA compounds, pharmaceutical compositions and methods of use
US6797820B2 (en) 1999-12-17 2004-09-28 Vicuron Pharmaceuticals Inc. Succinate compounds, compositions and methods of use and preparation
AR036053A1 (es) 2001-06-15 2004-08-04 Versicor Inc Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas
ATE360014T1 (de) * 2001-06-15 2007-05-15 Vicuron Pharm Inc Bicyclische pyrrolidinverbindungen
US20030068655A1 (en) * 2001-09-12 2003-04-10 Protiveris, Inc. Microcantilever apparatus and methods for detection of enzymes
FR2835835B1 (fr) * 2002-02-11 2004-04-16 Aventis Pharma Sa Nouveaux derives de la pyridazine, leur utilisation comme medicaments, compositions pharmaceutiques et leur procede de preparation
US7807177B2 (en) 2004-01-27 2010-10-05 Toshikazu Nakamura Segment of glycosylation-deficient HGFalpha-chain
EP2249828A1 (en) * 2008-01-07 2010-11-17 Janssen Pharmaceutica, N.V. Preparation of sulfamide derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659711A (en) * 1983-01-31 1987-04-21 Usv Pharmaceutical Corporation 1,2,3,4-Tetrahydrophthalazine and hexahydropyridazine compounds for treating hypertension
US4604407A (en) * 1985-04-04 1986-08-05 E. R. Squibb & Sons, Inc. Hydroxamates
JPH0670019B2 (ja) * 1989-07-21 1994-09-07 明治製菓株式会社 新抗生物質ｓｆ２１９７ｃ物質およびその製造法
JPH03157372A (ja) * 1989-11-13 1991-07-05 Yamanouchi Pharmaceut Co Ltd Ｙｌ―０１８６９ｐ物質及びその製造法
WO1991017982A1 (en) * 1990-05-21 1991-11-28 Sankyo Company, Limited Novel compound matristatin
AU2228292A (en) * 1991-06-14 1993-01-12 Research Corporation Technologies, Inc. Peptide derivatives of collagenase inhibitor

Also Published As

Publication number Publication date
EP0621270A1 (en) 1994-10-26
FI942094A0 (fi) 1994-05-06
CZ112694A3 (en) 1994-12-15
FI942094A (fi) 1994-07-01
KR100255203B1 (ko) 2000-05-01
CA2123104A1 (en) 1993-05-13
RU2091373C1 (ru) 1997-09-27
AU2799392A (en) 1993-06-07
NO941698D0 (no) 1994-05-06
EP0621270A4 (en) 1995-01-18
GR3033368T3 (en) 2000-09-29
NO941698L (no) 1994-07-07
ATE191713T1 (de) 2000-04-15
HU9401420D0 (en) 1994-08-29
DK0621270T3 (da) 2000-07-17
HUT67374A (en) 1995-03-28
AU661058B2 (en) 1995-07-13
US5643908A (en) 1997-07-01
WO1993009097A1 (en) 1993-05-13
JPH05194415A (ja) 1993-08-03
NO306507B1 (no) 1999-11-15
DE69230916D1 (de) 2000-05-18
EP0621270B1 (en) 2000-04-12
JPH05194414A (ja) 1993-08-03
DE69230916T2 (de) 2000-12-14

Similar Documents

Publication Publication Date Title
ES2145014T3 (es) Derivados de piperazina como inhibidores de la colagenasa.
KR960702464A (ko) Dc-89 유도체[dc-89 derivative]
DE69412534D1 (de) Piperazin-Derivate und ihre Verwendung als Calmodulin-Inhibitoren
WO2000004014A1 (fr) Derives de pyrimidine manifestant une activite antitumorale
DK0839798T3 (da) Mellemforbindelser til at fremstille retrovirale-proteaseinhibitorer
PL370834A1 (en) Pyrimidine derivatives
DE69108138D1 (de) Imidazopyridinderivate und ihre Verwendung.
NO993706D0 (no) Pyrrolidinderivater med fosfolipase A2 inhiberende aktivitet
IT1269176B (it) Eterobicicli ad attivita' fungicida
MX9604398A (es) Derivados de sulfonamida.
DK0641770T3 (da) Hidtil ukendte forbindelser med blodpladeaggegationsinhiberende aktivitet
ATE421524T1 (de) 5-ring-heterocyclen, ihre herstellung, ihre verwendung als inhibitoren der leukozytenadhäsion und sie enthaltende pharmazeutische präparate
NO20026095L (no) Kumarinderivater med COMT inhiberende aktivitet
DE69122812D1 (de) Glutathionderivat
ATE504572T1 (de) Derivate von aromatische heterocyclen enthaltende integraseinhibitoren
ITMI912421A1 (it) Derivati eterociclici di alcossiacrilati ad attivita' fungicida
ATE268769T1 (de) Pyrimidinderivate mit antitumor-wirkung

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 621270

Country of ref document: ES